← Leaderboards
Laurie S Conklin
Children'S Research Institute
$1,527,676
Attributed
$1,527,676
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314.3K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,527,676 · 2
By mechanism
U54$908,316 · 1
P50$619,360 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Yetrib Hathout$3,474,044
- Christopher Ryan Heier$3,542,686
- Yi-Wen Chen$5,035,323
- Kanneboyina Nagaraju$4,117,501
- Peter Phuong Nghiem$827,073
Others in their field
Top investigators on “S Disease”
- Lawrence Corey · Fred Hutchinson Cancer Center$643,566,627
- Jeffrey P Krischer · University Of South Florida$588,279,843
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$477,614,997
- David Heimbrook · Leidos Biomedical Research, Inc.$470,438,912
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$389,132,404
Research focus
S DiseaseDesignBone DensityColonoscopyAdrenal GlandsCushingoid HabitusAnti-Tumor Necrosis Factor TherapyAcuteBaseAffectBiological MarkersBiopsyBiopsy SpecimenBloodCostChildAptamerChildhoodClinical PredictorsClinical Trial Protocol DocumentClinical TrialsCohortCollectionCrohn&Apos
Grant awards (5)
Bridging pharmacodynamic biomarkers to endoscopic and clinical outcomes in pediatric inflammatory bowel disease$305,016
P50 · FY2020 · HD · contact PI
Bridging pharmacodynamic biomarkers to endoscopic and clinical outcomes in pediatric inflammatory bowel disease$314,344
P50 · FY2019 · HD · contact PI
Bridging pharmacodynamic biomarkers to endoscopic and clinical outcomes in pediatric inflammatory bowel disease$305,016
U54 · FY2018 · HD · contact PI
Bridging pharmacodynamic biomarkers to endoscopic and clinical outcomes in pediatric inflammatory bowel disease$301,650
U54 · FY2017 · HD · contact PI
Bridging pharmacodynamic biomarkers to endoscopic and clinical outcomes in pediatric inflammatory bowel disease$301,650
U54 · FY2016 · HD · contact PI